Bell Investment Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9
Closed -$460 1962
2024
Q4
$460 Buy
9
+2
+29% +$98 ﹤0.01% 1801
2024
Q3
$289 Hold
7
﹤0.01% 1842
2024
Q2
$338 Hold
7
﹤0.01% 1894
2024
Q1
$336 Sell
7
-18
-72% -$962 ﹤0.01% 1882
2023
Q4
$1.62K Sell
25
-4
-14% -$241 ﹤0.01% 1421
2023
Q3
$1.9K Sell
29
-7
-19% -$440 ﹤0.01% 1301
2023
Q2
$2.09K Buy
36
+10
+38% +$631 ﹤0.01% 1270
2023
Q1
$1.61K Buy
26
+17
+189% +$1.02K ﹤0.01% 1373
2022
Q4
$572 Hold
9
﹤0.01% 1750
2022
Q3
$1K Sell
9
-44
-83% -$3.28K ﹤0.01% 1652
2022
Q2
$4K Buy
+53
New +$3.81K ﹤0.01% 872

Other funds holding NARI

Bell Investment Advisors's NARI Position: Q1 2025 in Review

Bell Investment Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 9 shares — an estimated $460 sold.

Bell Investment Advisors first reported a position in NARI in Q2 2022 and held it in 11 quarters. The position peaked at $4K in Q2 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bell Investment Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 9 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $460.
  • Bell Investment Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2022 and held it in 11 quarters.
  • Bell Investment Advisors's Inari Medical, Inc. Common Stock position peaked at $4K in Q2 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bell Investment Advisors's 13F filing for Q1 2025, filed 16 May 2025.